Join ARMI at Cell & Gene Therapy International during Biotech Week Boston, where Chief Regulatory Officer Dr. Richard McFarland will moderate a panel on decentralized manufacturing for cell therapies.
ARMI will attend TERMIS-AM 2026, the premier North American conference for tissue engineering and regenerative medicine, bringing together researchers, clinicians, industry leaders, and innovators advancing the future of regenerative therapies.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
